Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Cognitive
Full-length adrenocorticotropic hormone — endocrine research peptide, melanocortin agonist.
Peptide B
Research
Membrane-active anticancer research peptide — selectively lyses cancer cell membranes.
Typical vial
5 mg
Typical dose
250 (diagnostic) mcg
Half-life
~10-15 minutes (plasma)
FDA status
Cosyntropin (ACTH 1-24) FDA approved as Cortrosyn. Repositor…
Typical vial
5 mg
Typical dose
Research-only mcg
Half-life
Variable
FDA status
Not FDA approved.
ACTH 1-39 (Corticotropin) effects
PNC-27 effects
ACTH 1-39 (Corticotropin) side effects
PNC-27 side effects
ACTH 1-39 (Corticotropin) dosing ranges
Adrenal stimulation test (clinical)
250 mcg · Single IV or IM dose · Diagnostic, one-time
Endocrine research
Variable · Per study protocol · Per study protocol
PNC-27 dosing ranges
In vitro / animal cancer research
Variable per protocol · Per study design · Per protocol
Human self-experimentation
Not recommended · — · —
ACTH 1-39 (Corticotropin): Full-length adrenocorticotropic hormone — endocrine research peptide, melanocortin agonist. Typical dose 250 (diagnostic) mcg. PNC-27: Membrane-active anticancer research peptide — selectively lyses cancer cell membranes. Typical dose Research-only mcg. Both fall under the Cognitive and Research categories.
Stacking ACTH 1-39 (Corticotropin) with PNC-27 is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
ACTH 1-39 (Corticotropin) is typically dosed: Single IV or IM dose for Adrenal stimulation test (clinical); Per study protocol for Endocrine research. PNC-27 is typically dosed: Per study design for In vitro / animal cancer research; — for Human self-experimentation.
ACTH 1-39 (Corticotropin): Cosyntropin (ACTH 1-24) FDA approved as Cortrosyn. Repository ACTH (porcine, full-length) FDA approved as Acthar Gel for infantile spasms, MS exacerbations, and other indications. PNC-27: Not FDA approved.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free